|
13th Annual Recipient
Joseph Schlessinger, Ph.D.
Yale University School of Medicine
Department of Pharmacology
New Haven, CT
|
Dr. Schlessinger will deliver his Award Lecture entitled Cell Signaling by receptor tyrosine kinases: from basic principles to cancer therapy, at the AACR 101st Annual Meeting 2010 in Washington, D.C. The Award ceremony and lecture will be held on Monday, April 19, 2010, from 5:00 p.m.-6:00 p.m. Learn more about the AACR 101st Annual Meeting 2010.
Learn more about the recipient of the 2009 Award, Dr. Napoleone Ferrara.
View the list of all prior recipients.
The Award and Lecture
The prestigious Pezcoller Foundation–AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown:
- who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research;
- who continues to be active in cancer research and has a record of recent, noteworthy publications; and
- whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.
The Award is intended to honor an individual scientist. However, more than one scientist may be co-nominated and selected to share the Award when their investigations are closely related in subject matter and have resulted in work that is worthy of the Award.
The Award consists of an unrestricted grant of €75,000, commemorative plaque, and full support to the winner and a guest to attend the AACR Annual Meeting. The winner of the 14th Annual Pezcoller Foundation-AACR International Award for Cancer Research will give a 50-minute Award lecture at the AACR Annual Meeting 2011 in Orlando, FL, U.S.A. (April 2-6, 2011).
Eligibility
- Eligible candidates are cancer researchers affiliated with institutions in academia, industry, or government that are involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world.
- Institutions or organizations are not eligible for the Award.
- Receipt of other major awards does not preclude a candidate from eligibility for the Award.
- No regard shall be given to race, gender, nationality, geographic location, or religious or political views.
Nomination Process
Nominations for the 2011 Award opens August 2010.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
Nominations must be submitted electronically to https://proposalcentral.altum.com, no later than 4:00 p.m. United States Eastern Standard Time on Wednesday, September 15, 2010. Paper nominations will not be accepted. The following materials must be submitted:
Nomination Letter, which must:
- be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
- specify the AACR Award for which the candidate is being nominated;
- concise description of the candidate's major scientific discovery in basic cancer research or significant contributions to translational cancer research, and the impact of these accomplishments on the field, with publications supporting these accomplishments directly referenced within the letter; and
- a concise description of the candidate's ongoing work which holds promise for continued substantive contributions to progress in the field of cancer.
Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.
Preferred file formats are *.doc. The candidate's CV may be submitted as a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.
Nomination Instructions
Will be available in August 2010.
Selection
Candidates for the Award will be considered by a prestigious international Selection Committee of renowned cancer leaders appointed by the President of the AACR in consultation with the Council of the Pezcoller Foundation. The Committee will consider all nominations as they have been submitted; the Committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR and the Council of the Pezcoller Foundation for final consideration and determination.
Selection of the Award winner will be made on the basis of the candidate's scientific accomplishments. No regard will be given to race, gender, nationality, or religious or political view.
Responsibilities of the Award Recipient
The winner will also present the Sixth Annual Stanley J. Korsmeyer Lecture in Padua, Italy, just prior to the official Award ceremony in Trento, Italy, in May 2011. Remarks to be made during the ceremony must be delivered to the Pezcoller Foundation at least four weeks prior to allow sufficient time for translation into Italian. Should the winner be unable to participate in either event, the Award must be forfeited and may be presented instead to the alternate.
In the rare event that there are dual winners of the Award, the cash award will be shared equally between them, and the AACR Executive Committee will determine which of the two co-recipients will present the Pezcoller-AACR Award Lecture at the AACR Annual Meeting.
The Stanley J. Korsmeyer Lecture
This Lectureship has been created through the Pezcoller Foundation, the Venetian Institute of Molecular Medicine, and the AACR to honor the tremendous contributions of the late Dr. Stanley J. Korsmeyer, an international leader in the field of cancer biology, whose pioneering observations opened the molecular era of programmed cell death.
Dr. Korsmeyer’s numerous accomplishments in the cancer field led to his being named the recipient of the Pezcoller Foundation-AACR International Award for Cancer Research in 2004. He subsequently presented a lecture at the Venetian Institute of Molecular Medicine – his last European lecture before his untimely death from cancer in 2005.
Through this Lectureship, the Foundation, the Institute, and the AACR wish to remember Dr. Korsmeyer in the manner he would have liked best – with the presentation of significant science and discussion among colleagues in cancer research. The lecture will be presented annually by the recipient of the Pezcoller-AACR Award, and will be delivered each year in May at the Venetian Institute of Molecular Medicine in Padua, Italy.
The Pezcoller Foundation was established in 1980 by Professor Alessio Pezcoller, a dedicated Italian surgeon who made important contributions to medicine during his career and who, through his foresight, vision, and generous gift in support of the formation of the Foundation, stimulated others to join this effort in sustaining the work of the Foundation. Professor Pezcoller has inspired scientists around the world to make significant advances in cancer research. In addition to sponsoring this prestigious Award, the Foundation also sponsors a series of symposia, publishes a journal, and supports awards for early-career scientists from Europe who have submitted highly rated abstracts for presentation at the AACR Annual Meeting.
Questions?
Monique P. Eversley, Program Coordinator
+1 (267) 646-0576; monique.eversley@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404